Under the aegis of the Department of Clinical Immunology of SGPGI-MS , he undertook several projects of the Indian Council of Medical Research which included a study of the genetic effects in the wake of the Bhopal Gas Tragedy of December 1984 and a study of Handigodu Syndrome prevalent in some parts of Karnataka which he identified as autosomal-dominant spondylo-epiphyseal dysplasia . He also undertook a task for Central Drug Research Institute ( CDRI ) when the institute developed '' Guggulipid '' , a hypolipideamic agent produced from the Ayurvedic drug , guggul . He completed the clinical trials for the phytopharmaceutical preparation which was subsequently cleared by the Drug Controller General of India for commercial marketing
Bhopal Gas Tragedy
Bhopal disaster
Shyam Swarup Agarwal